133 related articles for article (PubMed ID: 9731895)
1. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.
Ahuja V; Coleman RE; Herndon J; Patz EF
Cancer; 1998 Sep; 83(5):918-24. PubMed ID: 9731895
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
Hoang JK; Hoagland LF; Coleman RE; Coan AD; Herndon JE; Patz EF
J Clin Oncol; 2008 Mar; 26(9):1459-64. PubMed ID: 18349396
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer.
Li L; Hu M; Zhu H; Zhao W; Yang G; Yu J
Clin Lung Cancer; 2010 Sep; 11(5):335-40. PubMed ID: 20837459
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer.
Patz EF; Connolly J; Herndon J
AJR Am J Roentgenol; 2000 Mar; 174(3):769-74. PubMed ID: 10701623
[TBL] [Abstract][Full Text] [Related]
5. Is (18)F-FDG-PET/CT prognostic factor for survival in patients with small cell lung cancer? Single center experience.
Inal A; Kucukoner M; Kaplan MA; Urakci Z; Nas N; Guven M; Dostbil Z; Altindag S; Isikdogan A
Rev Port Pneumol; 2013; 19(6):260-5. PubMed ID: 23993406
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.
Vesselle H; Freeman JD; Wiens L; Stern J; Nguyen HQ; Hawes SE; Bastian P; Salskov A; Vallières E; Wood DE
Clin Cancer Res; 2007 Jun; 13(11):3255-63. PubMed ID: 17545531
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
Bütof R; Hofheinz F; Zöphel K; Stadelmann T; Schmollack J; Jentsch C; Löck S; Kotzerke J; Baumann M; van den Hoff J
J Nucl Med; 2015 Aug; 56(8):1150-6. PubMed ID: 26089549
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
Zaizen Y; Azuma K; Kurata S; Sadashima E; Hattori S; Sasada T; Imamura Y; Kaida H; Kawahara A; Kinoshita T; Ishibashi M; Hoshino T
Eur J Radiol; 2012 Dec; 81(12):4179-84. PubMed ID: 22884163
[TBL] [Abstract][Full Text] [Related]
10. High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
Lee YJ; Cho A; Cho BC; Yun M; Kim SK; Chang J; Moon JW; Park IK; Choi HJ; Kim JH
Clin Cancer Res; 2009 Apr; 15(7):2426-32. PubMed ID: 19318478
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images.
Zhang C; Liao C; Penney BC; Appelbaum DE; Simon CA; Pu Y
Radiology; 2015 Jun; 275(3):862-9. PubMed ID: 25584710
[TBL] [Abstract][Full Text] [Related]
12. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion.
Duysinx B; Corhay JL; Larock MP; Nguyen D; Bury T; Hustinx R; Louis R
Nucl Med Commun; 2008 Nov; 29(11):982-6. PubMed ID: 18836376
[TBL] [Abstract][Full Text] [Related]
14. Relationship between non-small cell lung cancer fluorodeoxyglucose uptake at positron emission tomography and surgical stage with relevance to patient prognosis.
Vesselle H; Turcotte E; Wiens L; Schmidt R; Takasugi JE; Lalani T; Vallières E; Wood DE
Clin Cancer Res; 2004 Jul; 10(14):4709-16. PubMed ID: 15269143
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with advanced non-small cell lung cancer: single center experience.
Inal A; Kucukoner M; Kaplan MA; Urakci Z; Karakus A; Komek H; Dostbil Z; Isikdogan A
J BUON; 2012; 17(4):724-8. PubMed ID: 23335532
[TBL] [Abstract][Full Text] [Related]
16. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications.
Cheran SK; Nielsen ND; Patz EF
AJR Am J Roentgenol; 2004 May; 182(5):1129-32. PubMed ID: 15100107
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
18. Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients.
Kim SJ; Chang S
Oncol Res Treat; 2015; 38(11):577-85. PubMed ID: 26599271
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy.
Kocher MR; Sharma A; Garrett-Mayer E; Ravenel JG
J Comput Assist Tomogr; 2018; 42(1):146-150. PubMed ID: 29251647
[TBL] [Abstract][Full Text] [Related]
20. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET.
Marom EM; Sarvis S; Herndon JE; Patz EF
Radiology; 2002 May; 223(2):453-9. PubMed ID: 11997552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]